ASCO22 - Highlights maag- en slokdarmcarcinoom, pancreascarcinoom en galwegtumoren

Koos van der Hoeven bespreekt met Hanneke van Laarhoven ontwikkelingen bij maag- en slokdarmcarcinoom, pancreascarcinoom en galwegtumoren. Aan bod komen onder andere de rol van biomarkers bij de tweedelijnsbehandeling van gemetastaseerd maagcarcinoom, immunotherapie bij maag-/slokdarmcarcinoom, antilichaam-geneesmiddelconjugaten bij galgangcarcinoom en tot slot sequentiële chemotherapie evenals de rol van bewegen bij het pancreascarcinoom.

Episode metadata supplied by the publisher feed · Published Jun 9, 2022

Embed this episode

Attribution link and audio player

Ready to play

ASCO22 - Highlights maag- en slokdarmcarcinoom, pancreascarcinoom en galwegtumoren

0:00 22:43

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Oncologie.nu?

This episode is 22 minutes long.

When was this Oncologie.nu episode published?

This episode was published on June 9, 2022.

Can I download this Oncologie.nu episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!